Source: Eur Respir J 2014; 43: 397-408
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Stolz Daiana, Kostikas Kostantinos, Blasi Francesco, Boersma Wim, Milenkovic Branislava, Lacoma Alicia, Louis Renaud, Aerts Joachim G., Welte Tobias, Torres Antoni, Rohde Gernot G.U., Boeck Lucas, Rakic Janko, Scherr Andreas, Hertel Sabine, Giersdorf Sven, Tamm Michael. Adrenomedullin refines mortality prediction by the BODE index in COPD: the “BODE-A” index. Eur Respir J 2014; 43: 397-408

Member's Comments

No comment yet.

Related content which might interest you: Can we assess COPD comorbidities by BODE index? Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Association between Frailty Index and BODE index with lung function and mortality in COPD Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 The BODE index and other composite variables in COPD Source: Annual Congress 2013 –Composite variables in COPD and update of prevalence worldwide Year: 2013 BODE index score changes before and after pulmonary rehabilitation Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 The BODE index in patient with COPD in Russia Source: Eur Respir J 2007; 30: Suppl. 51, 78s Year: 2007 Proadrenomedullin improves the prognostic property of the BODE index Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Pulmonary rehabilitation effects on BODE index in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 70s Year: 2006 The modified BODE index: validation with mortality in COPD Source: Eur Respir J 2008; 32: 1269-1274 Year: 2008 What is the best predictor of mortality in chronic obstructive pulmonary disease? (BODE index and CPET) Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Comparison of dyspnea scoring methods and BODE index with functional parameters in stable COPD Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Multidimensional system for assessment of COPD patients. Comparison with BODE index Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 The BODE index as a tool to predict survival in COPD lung transplant candidates Source: Eur Respir J 2010; 36: 1494-1495 Year: 2010 Is it possible to improve the prediction ability of the BODE index? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 The index distance-saturation product like predicting of mortality in patients with COPD Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment Year: 2008 Development and validation of a new comorbidity index for COPD Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 Associations between BODE index and systemic inflammatory biomarkers in COPD Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Comorbidities in COPD patients – their prevalence and correlation with BODE index Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Body composition by bioelectrical impedance predicts mortality in COPD patients Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005